For Media: UK Press Releases

This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com

News context

News Area (field_news_area)

News Topic (field_news_topic)

Country

November 22, 2024

Bayer Launches Berocca® Mind to Support Your Memory With Spanish Sage

September 27, 2024

BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months

September 25, 2024

AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies

September 17, 2024

Bayer submits application to MHRA for elinzanetant to treat moderate to severe vasomotor systems associated with menopause in women

September 16, 2024

Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer

September 06, 2024

Finerenone showed statistically significant improvement in cardiovascular outcomes in adults with a common form of heart failure with high unmet medical need

July 17, 2024

Darolutamide meets primary endpoint in Phase III ARANOTE trial in men with metastatic hormone-sensitive prostate cancer

July 12, 2024

AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease